Findings

What do systematic reviews say?

6 questions · 6 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2 · 33.3%GRADE not reported 0 · 0%Very low 2 · 33.3%Low 2 · 33.3%Moderate 0 · 0%High 0 · 0%

Closest answers

The findings closest to your search, judged one by one by TypeSafe's Jev model.

Direct match · question page
- Corticosteroids vs control · Early all‐cause mortality (≤ 3 months) Reported at: day 14; day 28; day 60; and in hospital
  Pharmacological agents for adults with acute respiratory distress syndrome 2019 · Cochrane Headline outcomes only
  RR 0.77 [0.57, 1.05]
  6 studies · 574 participants
  Low
Direct match · question page
- Corticosteroids vs control · Ventilator‐free days up to day 28
  Pharmacological agents for adults with acute respiratory distress syndrome 2019 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 494 participants
  Low
Direct match · question page
- Corticosteroids vs control · Late all‐cause mortality ( > 3 months) Reported at: 180 days
  Pharmacological agents for adults with acute respiratory distress syndrome 2019 · Cochrane Headline outcomes only
  RR 0.99 [0.64, 1.52]
  1 study · 180 participants
  Very low
Direct match · question page
- Corticosteroids vs control · Adverse events Defined as leading to discontinuation of study medication; or for studies with standard care control, defined by study authors as "serious adverse events"
  Pharmacological agents for adults with acute respiratory distress syndrome 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found
Direct match · question page
- Corticosteroids vs control · Duration of mechanical ventilation Measured in days
  Pharmacological agents for adults with acute respiratory distress syndrome 2019 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 277 participants
  Very low

Corticosteroids vs control

Early all‐cause mortality (≤ 3 months) Reported at: day 14; day 28; day 60; and in hospital · adults with acute respiratory distress syndrome

Corticosteroids showed no clear difference in early all‐cause mortality (≤ 3 months) Reported at: day 14; day 28;… compared with control (low certainty).

1 finding from 1 review

Pharmacological agents for adults with acute respiratory distress syndrome 2019 · Cochrane Headline outcomes only
RR 0.77 [0.57, 1.05]
6 studies · 574 participants
Low

Corticosteroids vs control

Late all‐cause mortality ( > 3 months · adults with acute respiratory distress syndrome

It is very uncertain whether corticosteroids changes late all‐cause mortality ( > 3 months) Reported at: 180 days compared with control (very low certainty).

1 finding from 1 review

Pharmacological agents for adults with acute respiratory distress syndrome 2019 · Cochrane Headline outcomes only
RR 0.99 [0.64, 1.52]
1 study · 180 participants
Very low

Corticosteroids vs control

Duration of mechanical ventilation · adults with acute respiratory distress syndrome

1 finding from 1 review

Pharmacological agents for adults with acute respiratory distress syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 277 participants
Very low

Corticosteroids vs control

Ventilator‐free days up to day 28 · adults with acute respiratory distress syndrome

1 finding from 1 review

Pharmacological agents for adults with acute respiratory distress syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 494 participants
Low

Adverse events Defined as leading to discontinuation of study medication; or for studies with standard care control, defined by study authors as "serious adverse events" · adults with acute respiratory distress syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological agents for adults with acute respiratory distress syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Corticosteroids vs control

Fitness to return to work at 12 months · adults with acute respiratory distress syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological agents for adults with acute respiratory distress syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found